Lilly Zyprexa "Dear Doctor" Letter Warns Of Diabetes Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
The letter notes that FDA has requested an atypical antipsychotics class warning describing the increased risk of hyperglycemia and diabetes.